NCT02744664View on ClinicalTrials.gov

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

August 15, 2017

Study Completion Date

August 15, 2017

Conditions
Lung Neoplasms
Interventions
PROCEDURE

Cryotherapy

After entering the group subject receive Cryotherapy on lung cancer

DRUG

Icotinib

After Cryotherapy, subjects begin Icotinib administration

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02744664 - Cryotherapy Combine Icotinib for Advanced NSCLC Treatment | Biotech Hunter | Biotech Hunter